269 related articles for article (PubMed ID: 2870796)
21. Differentiation and reduction of intracellular GTP levels in HL-60 and U937 cells upon treatment with IMP dehydrogenase inhibitors.
Inai K; Tsutani H; Yamauchi T; Nakamura T; Ueda T
Adv Exp Med Biol; 1998; 431():549-53. PubMed ID: 9598126
[No Abstract] [Full Text] [Related]
22. Synthesis, structure, and antiproliferative activity of selenophenfurin, an inosine 5'-monophosphate dehydrogenase inhibitor analogue of selenazofurin.
Franchetti P; Cappellacci L; Sheikha GA; Jayaram HN; Gurudutt VV; Sint T; Schneider BP; Jones WD; Goldstein BM; Perra G; De Montis A; Loi AG; La Colla P; Grifantini M
J Med Chem; 1997 May; 40(11):1731-7. PubMed ID: 9171883
[TBL] [Abstract][Full Text] [Related]
23. Growth inhibition and induction of phenotypic alterations in MCF-7 breast cancer cells by an IMP dehydrogenase inhibitor.
Sidi Y; Panet C; Wasserman L; Cyjon A; Novogrodsky A; Nordenberg J
Br J Cancer; 1988 Jul; 58(1):61-3. PubMed ID: 2901850
[No Abstract] [Full Text] [Related]
24. Modulation of IMP dehydrogenase activity and guanylate metabolism by tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide).
Lui MS; Faderan MA; Liepnieks JJ; Natsumeda Y; Olah E; Jayaram HN; Weber G
J Biol Chem; 1984 Apr; 259(8):5078-82. PubMed ID: 6143752
[TBL] [Abstract][Full Text] [Related]
25. Assay method for monitoring the inhibitory effects of antimetabolites on the activity of inosinate dehydrogenase in intact human CEM lymphocytes.
Balzarini J; De Clercq E
Biochem J; 1992 Nov; 287 ( Pt 3)(Pt 3):785-90. PubMed ID: 1359876
[TBL] [Abstract][Full Text] [Related]
26. Activity of ribavirin against Hantaan virus correlates with production of ribavirin-5'-triphosphate, not with inhibition of IMP dehydrogenase.
Sun Y; Chung DH; Chu YK; Jonsson CB; Parker WB
Antimicrob Agents Chemother; 2007 Jan; 51(1):84-8. PubMed ID: 17060520
[TBL] [Abstract][Full Text] [Related]
27. Induced maturation of the human promyelocytic leukemia cell line, HL-60, by 2-beta-D-ribofuranosylselenazole-4-carboxamide.
Lucas DL; Robins RK; Knight RD; Wright DG
Biochem Biophys Res Commun; 1983 Sep; 115(3):971-80. PubMed ID: 6138039
[TBL] [Abstract][Full Text] [Related]
28. Induction of erythroid differentiation and modulation of gene expression by tiazofurin in K-562 leukemia cells.
Olah E; Natsumeda Y; Ikegami T; Kote Z; Horanyi M; Szelenyi J; Paulik E; Kremmer T; Hollan SR; Sugar J
Proc Natl Acad Sci U S A; 1988 Sep; 85(17):6533-7. PubMed ID: 2901100
[TBL] [Abstract][Full Text] [Related]
29. Biochemical and antitumor activity of tiazofurin and its selenium analog (2-beta-D-ribofuranosyl-4-selenazolecarboxamide).
Boritzki TJ; Berry DA; Besserer JA; Cook PD; Fry DW; Leopold WR; Jackson RC
Biochem Pharmacol; 1985 Apr; 34(7):1109-14. PubMed ID: 3985993
[TBL] [Abstract][Full Text] [Related]
30. Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents.
Franchetti P; Grifantini M
Curr Med Chem; 1999 Jul; 6(7):599-614. PubMed ID: 10390603
[TBL] [Abstract][Full Text] [Related]
31. Inosine monophosphate dehydrogenase and myeloid cell maturation.
Knight RD; Mangum J; Lucas DL; Cooney DA; Khan EC; Wright DG
Blood; 1987 Feb; 69(2):634-9. PubMed ID: 2879579
[TBL] [Abstract][Full Text] [Related]
32. IMP dehydrogenase inhibitors reduce intracellular tetrahydrobiopterin levels through reduction of intracellular GTP levels. Indications of the regulation of GTP cyclohydrolase I activity by restriction of GTP availability in the cells.
Hatakeyama K; Harada T; Kagamiyama H
J Biol Chem; 1992 Oct; 267(29):20734-9. PubMed ID: 1356983
[TBL] [Abstract][Full Text] [Related]
33. Cell cycle dependent regulation of IMP dehydrogenase activity and effect of tiazofurin.
Szekeres T; Fritzer M; Pillwein K; Felzmann T; Chiba P
Life Sci; 1992; 51(16):1309-15. PubMed ID: 1357518
[TBL] [Abstract][Full Text] [Related]
34. Inhibition by tiazofurin of inosine 5'-phosphate dehydrogenase (IMP DH) activity in extracts of ovarian carcinomas.
Look KY; Sutton GP; Natsumeda Y; Eble JN; Stehman FB; Ehrlich CE; Olah E; Prajda N; Bosze P; Eckhardt S
Gynecol Oncol; 1992 Oct; 47(1):66-70. PubMed ID: 1358769
[TBL] [Abstract][Full Text] [Related]
35. Conversion of 2-beta-D-ribofuranosylselenazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties.
Jayaram HN; Ahluwalia GS; Dion RL; Gebeyehu G; Marquez VE; Kelley JA; Robins RK; Cooney DA; Johns DG
Biochem Pharmacol; 1983 Sep; 32(17):2633-6. PubMed ID: 6137224
[No Abstract] [Full Text] [Related]
36. Eicar (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide). A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis.
Balzarini J; Karlsson A; Wang L; Bohman C; Horská K; Votruba I; Fridland A; Van Aerschot A; Herdewijn P; De Clercq E
J Biol Chem; 1993 Nov; 268(33):24591-8. PubMed ID: 7901217
[TBL] [Abstract][Full Text] [Related]
37. IMP dehydrogenase: inhibition by the anti-leukemic drug, tiazofurin.
Yamada Y; Natsumeda Y; Yamaji Y; Jayaram HN; Tricot GJ; Hoffman R; Weber G
Leuk Res; 1989; 13(2):179-84. PubMed ID: 2564451
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of pyrimidine metabolism in myeloid leukemia cells by triazole and pyrazole nucleosides.
Matsumoto SS; Fujitaki JM; Nord LD; Willis RC; Lee VM; Sharma BS; Sanghvi YS; Kini GD; Revankar GR; Robins RK
Biochem Pharmacol; 1990 Feb; 39(3):455-62. PubMed ID: 1968339
[TBL] [Abstract][Full Text] [Related]
39. Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus.
Ölschläger S; Neyts J; Günther S
Antiviral Res; 2011 Aug; 91(2):89-93. PubMed ID: 21616094
[TBL] [Abstract][Full Text] [Related]
40. IMP dehydrogenase inhibitor, tiazofurin, induces apoptosis in K562 human erythroleukemia cells.
Vitale M; Zamai L; Falcieri E; Zauli G; Gobbi P; Santi S; Cinti C; Weber G
Cytometry; 1997 Feb; 30(1):61-6. PubMed ID: 9056744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]